Cite
HARVARD Citation
Morand, E. et al. (n.d.). 209 Attainment of low disease activity and remission with atacicept in patients with systemic lupus erythematosus and high disease activity in the phase IIb ADDRESS II study and its long-term extension. Lupus science & medicine. pp. A156-A157. [Online].